Evoke Wealth, LLC Dexcom Inc Transaction History

Evoke Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $2.19 Million - $3.61 Million	29,073 New	29,073 $3.61 Million
Q3 2022 Nov 07, 2022	SELL	$76.35 - $94.18 $19,621 - $24,204	-257 Reduced 20.51%	996 $80,000
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $52,896 - $103,388	778 Added 163.79%	1,253 $93,000
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $8,279 - $11,457	88 Added 22.74%	475 $243,000
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $259 - $325	-2 Reduced 0.51%	387 $208,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $5,122 - $6,872	-48 Reduced 10.98%	389 $212,000
Q2 2021 Aug 05, 2021	BUY	$80.99 - $107.93 $33,772 - $45,006	417 Added 2085.0%	437 $187,000
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $1,017 - $1,256	12 Added 150.0%	20 $7,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $501 - $842	8 New	8 $3,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.